Tapewire

Nasdaq · USD

TVTX

Travere Therapeutics, Inc.

Export transactions ↓
Tapewire entity
1562
SEC CIK
0001438533
Parsed reports
437

Last 12 months

Inside the activity.

0 purchase rows · 116 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202506
Jan 202605
Feb 2026017
Mar 202601
Apr 2026023
May 2026015
Jun 202602
Jul 202600
Aug 202605
Sep 2026041
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 10, 2018 Filed May 14, 2018 23:31 UTC
ASELAGE STEVEDirector · Chief Executive Officer
GrantCommon Stock 24,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-030054 · doc4.xml · nonDerivative · entry 1

ASELAGE STEVE · CIK 0001221599 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 245,883

Read SEC document
May 09, 2018 Filed May 12, 2018 01:07 UTC
LYONS GARY ADirector
GrantEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $26.52 $0.00
Disclosure

SEC source: 0001209191-18-029721 · doc4.xml · derivative · entry 2

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-05-08

F1 · derivative.exercise_date: The option shall vest in 4 equal quarterly installments following the date of grant.

Read SEC document
May 09, 2018 Filed May 12, 2018 01:07 UTC
LYONS GARY ADirector
GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029721 · doc4.xml · nonDerivative · entry 1

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,000

Read SEC document
May 09, 2018 Filed May 12, 2018 01:12 UTC
Orwin John ADirector
GrantEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $26.52 $0.00
Disclosure

SEC source: 0001209191-18-029726 · doc4.xml · derivative · entry 2

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-05-08

F1 · derivative.exercise_date: The option shall vest in 4 equal quarterly installments following the date of grant.

Read SEC document
May 09, 2018 Filed May 12, 2018 01:12 UTC
Orwin John ADirector
GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029726 · doc4.xml · nonDerivative · entry 1

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,875

Read SEC document
May 09, 2018 Filed May 12, 2018 01:11 UTC
Squarer RonDirector
GrantEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $26.52 $0.00
Disclosure

SEC source: 0001209191-18-029725 · doc4.xml · derivative · entry 2

Squarer Ron · CIK 0001454001 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-05-08

F1 · derivative.exercise_date: The option shall vest in 4 equal quarterly installments following the date of grant.

Read SEC document
May 09, 2018 Filed May 12, 2018 01:11 UTC
Squarer RonDirector
GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029725 · doc4.xml · nonDerivative · entry 1

Squarer Ron · CIK 0001454001 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,875

Read SEC document
May 09, 2018 Filed May 12, 2018 01:10 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $26.52 $0.00
Disclosure

SEC source: 0001209191-18-029724 · doc4.xml · derivative · entry 2

Baynes Roy D. · CIK 0001680739 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-05-08

F1 · derivative.exercise_date: The option shall vest in 4 equal quarterly installments following the date of grant.

Read SEC document
May 09, 2018 Filed May 12, 2018 01:10 UTC GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029724 · doc4.xml · nonDerivative · entry 1

Baynes Roy D. · CIK 0001680739 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Read SEC document
May 09, 2018 Filed May 12, 2018 01:09 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $26.52 $0.00
Disclosure

SEC source: 0001209191-18-029723 · doc4.xml · derivative · entry 2

Coughlin Timothy P · CIK 0001376043 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-05-08

F1 · derivative.exercise_date: The option shall vest in 4 equal quarterly installments following the date of grant.

Read SEC document
May 09, 2018 Filed May 12, 2018 01:09 UTC GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029723 · doc4.xml · nonDerivative · entry 1

Coughlin Timothy P · CIK 0001376043 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,000

Read SEC document
May 09, 2018 Filed May 12, 2018 01:09 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $26.52 $0.00
Disclosure

SEC source: 0001209191-18-029722 · doc4.xml · derivative · entry 2

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-05-08

F1 · derivative.exercise_date: The option shall vest in 4 equal quarterly installments following the date of grant.

Read SEC document
May 09, 2018 Filed May 12, 2018 01:09 UTC GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029722 · doc4.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,000

Read SEC document
May 09, 2018 Filed May 12, 2018 01:06 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $26.52 $0.00
Disclosure

SEC source: 0001209191-18-029720 · doc4.xml · derivative · entry 2

Meckler Jeffrey A · CIK 0001506916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-05-08

F1 · derivative.exercise_date: The option shall vest in 4 equal quarterly installments following the date of grant.

Read SEC document
May 09, 2018 Filed May 12, 2018 01:06 UTC GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029720 · doc4.xml · nonDerivative · entry 1

Meckler Jeffrey A · CIK 0001506916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,000

Read SEC document
March 07, 2018 Filed Mar 9, 2018 02:13 UTC
ASELAGE STEVEDirector · Chief Executive Officer
Exercise / conversionCommon Stock Purchase Warrants · Derivative 278 Not disclosed Strike: $6.00 Not disclosed
Disclosure

SEC source: 0001209191-18-018375 · doc4.xml · derivative · entry 2

ASELAGE STEVE · CIK 0001221599 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 278 shares

Expires 2018-08-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On August 15, 2013, in connection with a private placement of the Issuer's securities, the Reporting Person acquired 556 shares of the Issuer's common stock, par value $0.0001 per share, at a purchase price of $4.50 per share, and Common Stock Purchase Warrants to purchase up to an aggregate of 278 shares of common stock. The aggregate purchase price paid by the Reporting Person in the transaction was $2,502.

Read SEC document
March 07, 2018 Filed Mar 9, 2018 02:13 UTC
ASELAGE STEVEDirector · Chief Executive Officer
Exercise / conversionCommon Stock 278 $6.00 $1,668.00
Disclosure

SEC source: 0001209191-18-018375 · doc4.xml · nonDerivative · entry 1

ASELAGE STEVE · CIK 0001221599 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 221,383

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2018 Filed Feb 17, 2018 00:39 UTC
ROTE WILLIAM E.Senior Vice President, R&D
SaleCommon Stock 1,034 $21.50 $22,232.03
Disclosure

SEC source: 0001209191-18-011083 · doc4.xml · nonDerivative · entry 1

ROTE WILLIAM E. · CIK 0001698262 · Senior Vice President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,156

F1 · kind: Shares were sold to cover the tax obligation that occurred upon the vesting of an RSU pursuant to a previous sell to cover election.

Read SEC document
February 08, 2018 Filed Feb 13, 2018 01:42 UTC
REED ELIZABETH ESVP, GC & Corporate Secretary
GrantCommon Stock 1,769 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-009403 · doc4.xml · nonDerivative · entry 1

REED ELIZABETH E · CIK 0001283303 · SVP, GC & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,827

Read SEC document
February 08, 2018 Filed Feb 13, 2018 01:40 UTC
ROTE WILLIAM E.Senior Vice President, R&D
GrantCommon Stock 1,985 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-009401 · doc4.xml · nonDerivative · entry 1

ROTE WILLIAM E. · CIK 0001698262 · Senior Vice President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,190

F1 · balance_after: Includes 205 ordinary shares of the Issuer acquired by the reporting person on November 30, 2017 pursuant to an employee stock purchase program.

Read SEC document
February 08, 2018 Filed Feb 13, 2018 01:39 UTC
Clague LauraChief Financial Officer
GrantCommon Stock 2,033 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-009399 · doc4.xml · nonDerivative · entry 1

Clague Laura · CIK 0001388773 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,033

Read SEC document
February 08, 2018 Filed Feb 13, 2018 01:38 UTC
McFarlane Neil F.Chief Operating Officer
GrantCommon Stock 2,546 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-009398 · doc4.xml · nonDerivative · entry 1

McFarlane Neil F. · CIK 0001681098 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,448

F1 · balance_after: Includes 1,280 ordinary shares of the Issuer acquired by the reporting person on November 30, 2017 pursuant to an employee stock purchase program.

Read SEC document
February 08, 2018 Filed Feb 13, 2018 01:37 UTC
ASELAGE STEVEDirector · Chief Executive Officer
GrantCommon Stock 3,549 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-009395 · doc4.xml · nonDerivative · entry 1

ASELAGE STEVE · CIK 0001221599 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 221,105

Read SEC document
January 05, 2018 Filed Jan 9, 2018 00:58 UTC
REED ELIZABETH ESVP, GC & Corporate Secretary
SaleCommon Stock 942 $24.04 $22,645.68
Disclosure

SEC source: 0001209191-18-002805 · doc4.xml · nonDerivative · entry 1

REED ELIZABETH E · CIK 0001283303 · SVP, GC & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,058

F1 · kind: Shares were sold pursuant to a sell to cover election previously made, and confirmed by the Reporting Person during an open trading window, to cover the tax obligation that occurred upon the vesting of an RSU.

Read SEC document
December 26, 2017 Filed Dec 27, 2017 23:35 UTC
ASELAGE STEVEDirector · Chief Executive Officer
GiftCommon Stock 23,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-067459 · doc4.xml · nonDerivative · entry 2

ASELAGE STEVE · CIK 0001221599 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,556

Read SEC document
December 21, 2017 Filed Dec 27, 2017 23:35 UTC
ASELAGE STEVEDirector · Chief Executive Officer
GiftCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-067459 · doc4.xml · nonDerivative · entry 1

ASELAGE STEVE · CIK 0001221599 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,556

Read SEC document
August 16, 2017 Filed Aug 18, 2017 00:36 UTC
McFarlane Neil F.Chief Operating Officer
SaleCommon Stock 1,378 $22.50 $31,005.00
Disclosure

SEC source: 0001209191-17-049546 · doc4.xml · nonDerivative · entry 1

McFarlane Neil F. · CIK 0001681098 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,622

F1 · kind: Shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.

Read SEC document
June 14, 2017 Filed Jun 14, 2017 18:40 UTC
ASELAGE STEVEDirector · Chief Executive Officer
PurchaseCommon Stock 5,000 $17.85 $89,250.00
Disclosure

SEC source: 0001209191-17-039792 · doc4.xml · nonDerivative · entry 1

ASELAGE STEVE · CIK 0001221599 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 245,556

Read SEC document
May 17, 2017 Filed May 18, 2017 22:19 UTC
LYONS GARY ADirector
GrantEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $17.44 $0.00
Disclosure

SEC source: 0001209191-17-033723 · doc4.xml · derivative · entry 2

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2027-05-16

F1 · derivative.exercise_date: The option shall vest in 4 equal quarterly installments following the date of grant.

Read SEC document
May 17, 2017 Filed May 18, 2017 22:19 UTC
LYONS GARY ADirector
GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-033723 · doc4.xml · nonDerivative · entry 1

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,500

Read SEC document
May 17, 2017 Filed May 18, 2017 22:20 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $17.44 $0.00
Disclosure

SEC source: 0001209191-17-033725 · doc4.xml · derivative · entry 2

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2027-05-16

F1 · derivative.exercise_date: The option shall vest in 4 equal quarterly installments following the date of grant.

Read SEC document
May 17, 2017 Filed May 18, 2017 22:20 UTC GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-033725 · doc4.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,500

Read SEC document
May 17, 2017 Filed May 18, 2017 22:19 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $17.44 $0.00
Disclosure

SEC source: 0001209191-17-033722 · doc4.xml · derivative · entry 2

Meckler Jeffrey A · CIK 0001506916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2027-05-16

F1 · derivative.exercise_date: The option shall vest in 4 equal quarterly installments following the date of grant.

Read SEC document
May 17, 2017 Filed May 18, 2017 22:19 UTC GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-033722 · doc4.xml · nonDerivative · entry 1

Meckler Jeffrey A · CIK 0001506916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,500

Read SEC document
May 17, 2017 Filed May 18, 2017 22:18 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $17.44 $0.00
Disclosure

SEC source: 0001209191-17-033721 · doc4.xml · derivative · entry 2

Baynes Roy D. · CIK 0001680739 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2027-05-16

F1 · derivative.exercise_date: The option shall vest in 4 equal quarterly installments following the date of grant.

Read SEC document
May 17, 2017 Filed May 18, 2017 22:18 UTC GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-033721 · doc4.xml · nonDerivative · entry 1

Baynes Roy D. · CIK 0001680739 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,500

Read SEC document
May 17, 2017 Filed May 18, 2017 22:17 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $17.44 $0.00
Disclosure

SEC source: 0001209191-17-033720 · doc4.xml · derivative · entry 2

Coughlin Timothy P · CIK 0001376043 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2027-05-16

F1 · derivative.exercise_date: The option shall vest in 4 equal quarterly installments following the date of grant.

Read SEC document
May 17, 2017 Filed May 18, 2017 22:17 UTC GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-033720 · doc4.xml · nonDerivative · entry 1

Coughlin Timothy P · CIK 0001376043 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,500

Read SEC document
May 17, 2017 Filed May 18, 2017 22:16 UTC
Clague LauraChief Financial Officer
GrantEmployee stock option (right to buy) · Derivative 60,000 $0.00 Strike: $17.44 $0.00
Disclosure

SEC source: 0001209191-17-033719 · doc4.xml · derivative · entry 1

Clague Laura · CIK 0001388773 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2027-05-16

F1 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal quarterly installments from the date of grant.

Read SEC document
May 17, 2017 Filed May 18, 2017 22:15 UTC
McFarlane Neil F.Chief Operating Officer
GrantEmployee stock option (right to buy) · Derivative 90,000 $0.00 Strike: $17.44 $0.00
Disclosure

SEC source: 0001209191-17-033718 · doc4.xml · derivative · entry 1

McFarlane Neil F. · CIK 0001681098 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2027-05-16

F1 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal quarterly installments from the date of grant.

Read SEC document
May 17, 2017 Filed May 18, 2017 22:14 UTC
ASELAGE STEVEDirector · Chief Executive Officer
GrantEmployee stock option (right to buy) · Derivative 165,000 $0.00 Strike: $17.44 $0.00
Disclosure

SEC source: 0001209191-17-033717 · doc4.xml · derivative · entry 1

ASELAGE STEVE · CIK 0001221599 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,000

Underlying: Common Stock · 165,000 shares

Expires 2027-05-16

F1 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal quarterly installments from the date of grant.

Read SEC document
April 10, 2017 Filed Apr 13, 2017 00:27 UTC
Squarer RonDirector
GrantStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $18.07 $0.00
Disclosure

SEC source: 0001209191-17-026747 · doc4.xml · derivative · entry 2

Squarer Ron · CIK 0001454001 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock · 17,500 shares

Expires 2027-04-09

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in twelve equal quarterly installments following the grant date.

Read SEC document
April 10, 2017 Filed Apr 13, 2017 00:27 UTC
Squarer RonDirector
GrantCommon Stock 4,375 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-026747 · doc4.xml · nonDerivative · entry 1

Squarer Ron · CIK 0001454001 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,375

Read SEC document
March 23, 2017 Filed Mar 27, 2017 23:58 UTC
Orwin John ADirector
GrantStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $17.53 $0.00
Disclosure

SEC source: 0001209191-17-023016 · doc4.xml · derivative · entry 2

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock · 17,500 shares

Expires 2027-03-22

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in twelve equal quarterly installments following the grant date.

Read SEC document
March 23, 2017 Filed Mar 27, 2017 23:58 UTC
Orwin John ADirector
GrantCommon Stock 4,375 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-023016 · doc4.xml · nonDerivative · entry 1

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,375

Read SEC document
February 13, 2017 Filed Feb 16, 2017 01:03 UTC
ROTE WILLIAM E.Senior Vice President, R&D
GrantEmployee Stock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $20.61 $0.00
Disclosure

SEC source: 0001209191-17-011305 · doc4.xml · derivative · entry 2

ROTE WILLIAM E. · CIK 0001698262 · Senior Vice President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2027-02-12

F1 · derivative.exercise_date: One fourth of the shares subject to the stock option shall vest and become exercisable on the first anniversary of the date of grant, and the remaining shares shall vest and become exercisable in twelve equal quarterly installments thereafter.

Read SEC document
February 13, 2017 Filed Feb 16, 2017 01:03 UTC
ROTE WILLIAM E.Senior Vice President, R&D
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-011305 · doc4.xml · nonDerivative · entry 1

ROTE WILLIAM E. · CIK 0001698262 · Senior Vice President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
January 04, 2017 Filed Jan 6, 2017 21:22 UTC
REED ELIZABETH ESVP, GC & Corporate Secretary
GrantEmployee Stock Options (Right to Buy) · Derivative 50,000 $0.00 Strike: $19.08 $0.00
Disclosure

SEC source: 0001209191-17-002649 · doc4.xml · derivative · entry 2

REED ELIZABETH E · CIK 0001283303 · SVP, GC & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2027-01-03

F1 · derivative.exercise_date: One fourth of the shares subject to the stock option shall vest and become exercisable on the first anniversary of the date of grant, and the remaining shares shall vest and become exercisable in twelve equal quarterly installments thereafter.

Read SEC document
January 04, 2017 Filed Jan 6, 2017 21:22 UTC
REED ELIZABETH ESVP, GC & Corporate Secretary
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-002649 · doc4.xml · nonDerivative · entry 1

REED ELIZABETH E · CIK 0001283303 · SVP, GC & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
November 22, 2016 Filed Nov 23, 2016 21:25 UTC
ASELAGE STEVEDirector · Chief Executive Officer
SaleCommon Stock 3,200 $21.30 $68,160.00
Disclosure

SEC source: 0001209191-16-151969 · doc4.xml · nonDerivative · entry 3

ASELAGE STEVE · CIK 0001221599 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,556

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.25 to $21.405, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.